Evotec snares €250m in Sanofi discovery deal

Sanofi is has struck a five-year strategic alliance with drug discovery company Evotec – which will also be a boost for Evotec's partners, as the company will gain access to Sanofi's library of more than 1 million small molecules.

Sanofi is has struck a five-year strategic alliance with drug discovery company Evotec – which will also be a boost for Evotec's partners, as the company will gain access to Sanofi's library of more than 1 million small molecules.

The French drug maker will commit €250m to Evotec, to be paid out over the next five years; this includes...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip